PMID: 8947924Nov 1, 1996Paper

Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence

Neurochemical Research
Stanley M Crain, K F Shen

Abstract

Electrophysiologic studies of opioid effects on nociceptive types of dorsal root ganglion (DRG) neurons in organotypic cultures have shown that morphine and most mu, delta, and kappa opioid agonists can elicit bimodal excitatory as well as inhibitory modulation of the action potential duration (APD) of these cells. Excitatory opioid effects have been shown to be mediated by opioid receptors that are coupled via Gs to cyclic AMP-dependent ionic conductances that prolong the APD, whereas inhibitory opioid effects are mediated by opioid receptors coupled via Gi/Go to ionic conductances that shorten the APD. Selective blockade of excitatory opioid receptor functions by low (ca. pM) concentrations of naloxone, naltrexone, etorphine and other specific agents markedly increases the inhibitory potency of morphine or other bimodally acting agonists and attenuates development of tolerance/dependence. These in vitro studies have been confirmed by tail-flick assays showing that acute co-treatment of mice with morphine plus ultra-low-dose naltrexone or etorphine remarkably enhances the antinociceptive potency of morphine whereas chronic co-treatment attenuates development of tolerance and naloxone-precipitated withdrawal-jumping symptoms.

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·A W MudgeG D Fischbach
Jul 1, 1990·Neuropharmacology·J M FujimotoL F Tseng
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R A GrossR L Macdonald
Feb 1, 1990·Trends in Pharmacological Sciences·S M Crain, K F Shen
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M MiyakeR A North
May 1, 1967·British Journal of Pharmacology and Chemotherapy·G F BlaneR E Lister
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R A CrucianiM H Makman

❮ Previous
Next ❯

Citations

Dec 26, 2001·Brain Research. Brain Research Reviews·J G Liu, K J Anand
Jun 6, 2003·Progress in Neurobiology·Jana Sawynok, Xue Jun Liu
Feb 27, 2001·Hearing Research·T L Sahley, R H Nodar
Dec 26, 2006·Journal of Palliative Medicine·Jane E Loitman
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·P Y LawH H Loh
Apr 21, 2010·Pediatrics·Kanwaljeet J S AnandUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Resear
Oct 18, 2011·Cellular and Molecular Life Sciences : CMLS·H A TejedaR Henriksson
Sep 22, 2010·Neurochemical Research·Eric J Simon, Irma Onoprishvili
Aug 4, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Salim M HayekNagy Mekhail
Apr 4, 2012·Expert Opinion on Drug Discovery·Mellar P Davis
Mar 29, 2013·Expert Opinion on Drug Safety·Mellar DavisPam Gamier
Mar 10, 2010·Neurochemistry International·Flavie KersantéCatherine Mollereau
Dec 9, 2008·Epilepsy Research·Maryam RoshanpourAhmad Reza Dehpour
Dec 14, 2007·Pharmacology & Therapeutics·Thomas Koch, Volker Höllt
Aug 25, 2005·Clinical Therapeutics·Charles B BerdeDick Tibboel
Jul 13, 2005·Pediatric Clinics of North America·Christine Greco, Charles Berde
Aug 4, 2015·Brain Research Bulletin·Kornel KiralyMahmoud Al-Khrasani
Oct 1, 2014·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·Kelly VasquenzaSabine Kost-Byerly
Nov 7, 2014·Frontiers in Synaptic Neuroscience·Sean Austin O LimDaniel S McGehee
Apr 18, 2000·Emergency Medicine Clinics of North America·R Olmedo, R S Hoffman
Jul 16, 1999·Clinical and Experimental Pharmacology & Physiology·M Connor, M D Christie
Oct 6, 1997·Science·E J Nestler, G K Aghajanian
Sep 21, 2001·Indian Journal of Pediatrics·M Yaster, D G Nichols
Apr 9, 2010·European Journal of Anaesthesiology·Myron Yaster
Jul 21, 1998·Annals of the New York Academy of Sciences·S M Crain, K F Shen
Jul 21, 1998·Annals of the New York Academy of Sciences·G WuR W Ledeen
Apr 16, 2019·The Clinical Journal of Pain·Julia C Finkel, Jennifer Pukish
Nov 1, 2018·Molecular Psychiatry·Jun OhLea T Grinberg
Oct 4, 2007·Behavioural Pharmacology·Masoud FereidoniAbolhasan Ahmadiani
Oct 5, 2018·Molecular Neurobiology·Meritxell Llorca-TorralbaEsther Berrocoso
May 26, 2020·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T A Mariqueo, J Zúñiga-Hernández
Nov 27, 1999·Annales Françaises D'anesthèsie Et De Rèanimation·A MullerJ P Loeffler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.